| Year |
Citation |
Score |
| 2019 |
Jiang J, Yu Y, Kinjo E, Du Y, Nguyen H, Dingledine R. Suppressing pro-inflammatory prostaglandin signaling attenuates excitotoxicity-associated neuronal inflammation and injury. Neuropharmacology. PMID 30763657 DOI: 10.1016/J.Neuropharm.2019.02.011 |
0.637 |
|
| 2019 |
Qiu J, Li Q, Bell KA, Yao X, Du Y, Zhang E, Yu JJ, Yu Y, Shi Z, Jiang J. Small-molecule inhibition of prostaglandin E receptor 2 impairs cyclooxygenase-associated malignant glioma growth. British Journal of Pharmacology. PMID 30761522 DOI: 10.1111/Bph.14622 |
0.606 |
|
| 2017 |
Hartings JA, York J, Carroll CP, Hinzman JM, Mahoney E, Krueger B, Winkler MKL, Major S, Horst V, Jahnke P, Woitzik J, Kola V, Du Y, Hagen M, Jiang J, et al. Subarachnoid blood acutely induces spreading depolarizations and early cortical infarction. Brain : a Journal of Neurology. 140: 2673-2690. PMID 28969382 DOI: 10.1093/Brain/Awx214 |
0.589 |
|
| 2017 |
Kang X, Qiu J, Li Q, Bell KA, Du Y, Jung DW, Lee JY, Hao J, Jiang J. Cyclooxygenase-2 contributes to oxidopamine-mediated neuronal inflammation and injury via the prostaglandin E2 receptor EP2 subtype. Scientific Reports. 7: 9459. PMID 28842681 DOI: 10.1038/S41598-017-09528-Z |
0.621 |
|
| 2017 |
Qiu J, Du Y, Li Q, Shi Z, Jiang J. Abstract 3114: The role of prostaglandin signaling in human glioblastoma cell activities and growth in vitro and in vivo Cancer Research. 77: 3114-3114. DOI: 10.1158/1538-7445.Am2017-3114 |
0.587 |
|
| 2016 |
Dey A, Kang X, Qiu J, Du Y, Jiang J. Anti-Inflammatory Small Molecules To Treat Seizures and Epilepsy: From Bench to Bedside. Trends in Pharmacological Sciences. PMID 27062228 DOI: 10.1016/J.Tips.2016.03.001 |
0.615 |
|
| 2015 |
Du Y, Kemper T, Qiu J, Jiang J. Defining the therapeutic time window for suppressing the inflammatory prostaglandin E2 signaling after status epilepticus. Expert Review of Neurotherapeutics. PMID 26689339 DOI: 10.1586/14737175.2016.1134322 |
0.61 |
|
| 2015 |
Du Y, Seibenhener ML, Yan J, Jiang J, Wooten MC. aPKC phosphorylation of HDAC6 results in increased deacetylation activity. Plos One. 10: e0123191. PMID 25860570 DOI: 10.1371/Journal.Pone.0123191 |
0.603 |
|
| 2014 |
Calderilla-Barbosa L, Seibenhener ML, Du Y, Diaz-Meco MT, Moscat J, Yan J, Wooten MW, Wooten MC. Interaction of SQSTM1 with the motor protein dynein--SQSTM1 is required for normal dynein function and trafficking. Journal of Cell Science. 127: 4052-63. PMID 25015291 DOI: 10.1242/Jcs.152363 |
0.566 |
|
| 2013 |
Seibenhener ML, Zhao T, Du Y, Calderilla-Barbosa L, Yan J, Jiang J, Wooten MW, Wooten MC. Behavioral effects of SQSTM1/p62 overexpression in mice: support for a mitochondrial role in depression and anxiety. Behavioural Brain Research. 248: 94-103. PMID 23591541 DOI: 10.1016/J.Bbr.2013.04.006 |
0.661 |
|
| 2013 |
Seibenhener ML, Du Y, Diaz-Meco MT, Moscat J, Wooten MC, Wooten MW. A role for sequestosome 1/p62 in mitochondrial dynamics, import and genome integrity. Biochimica Et Biophysica Acta. 1833: 452-9. PMID 23147249 DOI: 10.1016/J.Bbamcr.2012.11.004 |
0.601 |
|
| 2009 |
Du Y, Wooten MC, Wooten MW. Oxidative damage to the promoter region of SQSTM1/p62 is common to neurodegenerative disease. Neurobiology of Disease. 35: 302-10. PMID 19481605 DOI: 10.1016/J.Nbd.2009.05.015 |
0.614 |
|
| 2009 |
Du Y, Wooten MC, Gearing M, Wooten MW. Age-associated oxidative damage to the p62 promoter: implications for Alzheimer disease. Free Radical Biology & Medicine. 46: 492-501. PMID 19071211 DOI: 10.1016/J.Freeradbiomed.2008.11.003 |
0.619 |
|
| Show low-probability matches. |